DaVita (DVA) revenue

Revenue · fiscal 2025
$13.64B

DaVita (DVA) reported revenue of $13.64B in fiscal 2025 (the year ended December 31, 2025). That is 6.5% higher than the $12.82B of fiscal 2024. Figures as of 18 Nov 2026, 09:50 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$13.64B
Change on fiscal 2024
+6.5%
Growth, 5 years
+3.4% a year
Highest on record
$13.64Bfiscal 2025
Lowest on record
$10.71Bfiscal 2016
Fiscal years on record
102016–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

DaVita revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 3.4% a year. Across the 10 fiscal years on record (2016–2025), the highest was $13.64B in fiscal 2025 and the lowest $10.71B in fiscal 2016.

History · 10 fiscal years

Revenue by fiscal year

DaVita revenue, year by year

DaVita (DVA) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$13.64B 6.5% up
2024$12.82B 5.6% up
2023$12.14B 4.6% up
2022$11.61B 0.1% down
2021$11.62B 0.6% up
2020$11.55B 1.4% up
2019$11.39B 0.1% down
2018$11.40B 4.9% up
2017$10.88B 1.6% up
2016$10.71B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of DaVita and comparable companies
CompanyRevenueFiscal year
Fresenius Medical Care FMS€19.63B2025
Kymera Therapeutics KYMR$39.21M2025
DaVita DVA$13.64B2025
Halozyme Therapeutics HALO$1.40B2025
Universal Health Services UHS$17.36B2025
Repligen RGEN$738.26M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on DVA

DaVita, figure by figure

DaVita (DVA) overview: price, valuation and scorecardAll health care companies by market value

DaVita revenue: questions and answers

What is DaVita's revenue?

DaVita (DVA) reported revenue of $13.64B in fiscal 2025 (the year ended December 31, 2025). That is 6.5% higher than the $12.82B of fiscal 2024.

What is the growth rate of DaVita's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 3.4% a year.

What are the highest and lowest revenue figures on record for DaVita?

Across the 10 fiscal years on record (2016–2025), the highest was $13.64B in fiscal 2025 and the lowest $10.71B in fiscal 2016.

How is DaVita's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For DaVita it is on record here for 10 fiscal years, 2016 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “DaVita (DVA) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/DVA/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.